RIGL
Rigel Pharmaceuticals, Inc.Healthcare$27.53
▲ Bullish
Mkt Cap: $508.6M|Float: 18.2M|SI: 20.5%|DTC: 9.7
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
34.5%
52W Range
$16-$52
ATR(14)
$0.98
Exp. Move
±11.3%
P/C Ratio
0.34
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
RIGL Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.1M
- Max Pain
- $29.00
- Expected Move
- ±11.3%
- Put/Call OI
- 0.34
- Net Premium
- $0.0M
- Spot Price
- $27.53
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.12 | ±11.3% | $24.41 | $30.66 |
| 2026-05-15 | 43 | ±$3.55 | ±12.9% | $23.98 | $31.08 |
| 2026-06-18 | 77 | ±$8.75 | ±31.8% | $18.78 | $36.28 |
| 2026-09-18 | 169 | ±$10.90 | ±39.6% | $16.63 | $38.43 |
Explore RIGL options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.